Table 2 Prior MDS Therapies
Treated Population | (N = 19) |
|---|---|
Prior Therapies − Median (Range) | 1 (0–6) |
N (%) | |
Chemotherapy | 2 (11) |
Immunotherapy | 1 (5) |
G-CSF | 3 (16) |
Investigational Agent/Drug | 2 (11) |
Erythropoietin | 10 (53) |
Steroids | 3 (16) |
Vitamins | 2 (11) |
Lenalidomide | 3 (16) |